Nephrotoxicity of targeted therapy used to treat lung cancer

Lung cancer is the leading cause of cancer-related death worldwide, especially non-small cell lung cancer. Early diagnosis and better treatment choices have already provided a more promising prognosis for cancer patients. In targeted therapy, antagonists target specific genes supporting cancer growt...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Qiuling Li, Jieshan Lin, Guojun Hao, Aihua Xie, Shuangxin Liu, Bin Tang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-07-01
Subjects:	lung cancer targeted therapy EGFR TKIs ALK TKIs nephrotoxicity
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1369118/full